Altogether, our results suggested that although there was a slight reduction of serum IL-6 and TNF-α levels in the hyposmia group, both of the two pro-inflammatory cytokine levels in serum were not associated with hyposmia occurrence, severity or recovery in COVID-19 patients. The gene discussed is IL6; the disease is COVID-19.